Trial · NCT00503113
Adverse events288
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 288
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Influenza | Infections and infestations | Ibandronate 3 mg Injection | 37 | 263 | |
| other | Influenza | Infections and infestations | Ibandronate 3 mg Infusion | 32 | 263 | |
| other | Influenza | Infections and infestations | Alendronate 70 mg Oral | 30 | 267 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Injection | 26 | 263 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Infusion | 29 | 263 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Alendronate 70 mg Oral | 25 | 267 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Injection | 22 | 263 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Infusion | 28 | 263 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Alendronate 70 mg Oral | 27 | 267 | |
| other | Hypertension | Vascular disorders | Ibandronate 3 mg Injection | 23 | 263 | |
| other | Hypertension | Vascular disorders | Ibandronate 3 mg Infusion | 28 | 263 | |
| other | Hypertension | Vascular disorders | Alendronate 70 mg Oral | 16 | 267 | |
| other | Pain in Extremity | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Injection | 22 | 263 | |
| other | Pain in Extremity | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Infusion | 23 | 263 | |
| other | Pain in Extremity | Musculoskeletal and connective tissue disorders | Alendronate 70 mg Oral | 21 | 267 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Injection | 22 | 263 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Infusion | 14 | 263 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Alendronate 70 mg Oral | 6 | 267 | |
| other | Musculoskeletal Pain | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Injection | 19 | 263 | |
| other | Musculoskeletal Pain | Musculoskeletal and connective tissue disorders | Ibandronate 3 mg Infusion | 15 | 263 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00503113/events